about
Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and PraziquantelIn vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosineIn vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasitesSynthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway.CD44 ligation with A3D8 antibody induces apoptosis in acute myeloid leukemia cells through binding to CD44s and clustering lipid rafts.Role of lipid rafts in liver health and diseaseInvolvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria.Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signalingDifferent associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.Tuning membrane phase separation using nonlipid amphiphiles.Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy.Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeastNerve growth factor/p75 neurotrophin receptor-mediated sensitization of rat sensory neurons depends on membrane cholesterol.Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancerLipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway.Caenorhabditis elegans as a platform to study the mechanism of action of synthetic antitumor lipidsGreen tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells.Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum.Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells.Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding.Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.Necroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells.Prognostic value of Flotillin-1 expression in patients with solid tumors.Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphomaLipid raft involvement in yeast cell growth and death.Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.Membrane perturbation through novel cell-penetrating peptides influences intracellular accumulation of imatinib mesylate in CML cells.Isolation of Lipid Rafts Through Discontinuous Sucrose Gradient Centrifugation and Fas/CD95 Death Receptor Localization in Raft Fractions.
P2860
Q27304398-0D06EFF9-5EFA-4DDE-BDAF-4072AE2D3C11Q27339703-4BDA12F0-8B9D-413D-9958-0200C6DA730DQ28482212-CEC7022A-7D15-412E-A692-FA03843E224CQ33855963-3B8338BA-8296-4655-AE91-89298BEA42CEQ34380921-E5928F99-212F-4F97-BE7D-5F06742AEC7AQ35012726-90CBE0B8-724B-4989-A167-B238330397FCQ35064991-BABC82E3-A84B-44FC-A1AA-D67869544E30Q35150394-B75A518A-B39E-460A-BEB1-F301B1771C50Q35579670-D50ACE96-7279-4E4C-99B5-263E8CABF9B1Q35743337-74317E91-8473-4A79-8380-9A1C8DA4BEE3Q35987417-A229216C-9C67-4443-ABDA-AC5AA05ED5CBQ36001206-817DBAD9-7599-4F4F-BB79-0E254CA3F152Q36708592-FF2A8EA2-66FC-43CC-A7A0-0DCE45B7B73BQ37446222-5C3F9B37-5225-4171-8B3E-F73126426B82Q37676743-D98BD1D9-F068-4661-AADD-7902E47D95FDQ38363543-2CEDC418-8BF2-488B-B8A8-64C8060A5D8DQ38816110-4A1A9480-0CA2-46D6-B926-F342291B632CQ38931076-96F2AB0C-8D1C-498C-B297-09D4B2FF5D65Q39410289-02F1C18A-E614-4CBD-B79A-89C8D02183C2Q39447548-516C6A10-9257-4AD1-8382-E01B6C2DD59EQ39549404-542D1C5C-771F-455E-9460-6451C6E8DCA3Q39560067-0022F66B-7645-4921-BC85-11DC856906E1Q40084369-83BD3908-D6CE-45FF-B03B-95471700C5CAQ41575088-055BE60C-4965-415B-99DD-CB26083C24F7Q41592845-E3B14B4E-9F7C-4665-9641-960D4EBD9463Q42142419-4E9DD03A-349D-4B5B-935F-24B34EA4757DQ42433327-6A8CB480-F422-4C0B-A52A-1035E8A6D91AQ42747951-AFBC9DD9-E0F1-4533-A2ED-009F82F79C4CQ50092037-0844629C-EFEA-4577-8F6B-4C49EC53AA5CQ51197685-AC60AFF0-BE71-4187-A5E8-96F6D8D17AA4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lipid raft-targeted therapy in multiple myeloma.
@ast
Lipid raft-targeted therapy in multiple myeloma.
@en
Lipid raft-targeted therapy in multiple myeloma.
@nl
type
label
Lipid raft-targeted therapy in multiple myeloma.
@ast
Lipid raft-targeted therapy in multiple myeloma.
@en
Lipid raft-targeted therapy in multiple myeloma.
@nl
prefLabel
Lipid raft-targeted therapy in multiple myeloma.
@ast
Lipid raft-targeted therapy in multiple myeloma.
@en
Lipid raft-targeted therapy in multiple myeloma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Lipid raft-targeted therapy in multiple myeloma
@en
P2093
F Mollinedo
J de la Iglesia-Vicente
M A Campanero
P2860
P2888
P304
P356
10.1038/ONC.2010.131
P407
P577
2010-04-26T00:00:00Z
P5875
P6179
1012097873